Search Results - "Herzig, Roger H."

The VR-DCEP regimen rescues mobilization failures and controls refractory disease in multiple myeloma by Krem, Maxwell M., Reynolds, Samuel B., Hashmi, Hamza, Manapuram, Suresh, Jayswal, Rani, Weiss, Heidi L., Baize, Timothy C., Figg, Lindsey R., Basu, Soumit K., Monohan, Gregory, Herzig, Roger H.

Get full text

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease by Jacobsohn, David A., Arora, Mukta, Klein, John P., Hassebroek, Anna, Flowers, Mary E., Cutler, Corey S., Urbano-Ispizua, Alvaro, Bolwell, Brian J., Antin, Joseph H., Boyiadzis, Michael, Cahn, Jean-Yves, Cairo, Mitchell S., Herzig, Roger H., Isola, Luis M., Klumpp, Thomas R., Lee, Stephanie J., Petersdorf, Effie W., Santarone, Stella, Gale, Robert P., Schouten, Harry C., Spellman, Stephen R., Weisdorf, Daniel J., Wingard, John R., Horowitz, Mary M., Pavletic, Steven Z.

“…There is a paucity of information regarding the factors that affect nonrelapse mortality (NRM) and overall survival among children that develop chronic…”
Get full text

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study by Metayer, Catherine, Curtis, Rochelle E., Vose, Julie, Sobocinski, Kathleen A., Horowitz, Mary M., Bhatia, Smita, Fay, Joseph W., Freytes, Cesar O., Goldstein, Steven C., Herzig, Roger H., Keating, Armand, Miller, Carol B., Nevill, Thomas J., Pecora, Andrew L., Rizzo, J. Douglas, Williams, Stephanie F., Li, Chin-Yang, Travis, Lois B., Weisdorf, Daniel J.

“…Although numerous reports indicate that patients receiving autotransplants for lymphoma are at increased risk for myelodysplastic syndrome (MDS)/acute myeloid…”
Get full text

High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later by Lazarus, Hillard M, Phillips, Gordon L, Herzig, Roger H, Hurd, David D, Wolff, Steven N, Herzig, Geoffrey P

Get full text

Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells by Zhai, QL, Qiu, LG, Li, Q, Meng, HX, Han, JL, Herzig, RH, Han, ZC

“…State Key Laboratory of Experimental Hematology, National Research Center of Stem Cell Engineering and Technology, Institute of Hematology & Hospital of Blood…”
Get full text

Positive pregnancy tests in a nongravid, premenopausal woman due to hCG β-chain production by multiple myeloma by SLONE, Stephen P, AHMED, Zakaria, COLE, Laurence A, ELIN, Ronald J, MARTIN, Alvin W, HERZIG, Roger H, HERZIG, Geoffrey P, MILLER, James J

“…Positive pregnancy test results occurred in a nongravid, premenopausal woman while she was receiving chemotherapy for multiple myeloma. We tested 2 hypotheses…”
Get full text

Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients by FLEMING, Donald R, ZIEGLER, Craig, BAIZE, Timothy, MUDD, Leslie, GOLDSMITH, George H, HERZIG, Roger H

“…An open labeled randomized trial comparing the efficacy and cost of empirically applied cefepime (C) as monotherapy versus combination therapy consisting of…”
Get full text

Socioeconomic Disparities Affect Survival of Classical Hodgkin Lymphoma in a Statewide Cancer Registry Analysis by Myint, Zin W., Shrestha, Runa, Chen, Quan, Huang, Bin, Goldberg, Amit, Ramlal, Reshma, Monohan, Gregory, Fleischman, Roger A., Herzig, Roger H., Hildebrandt, Gerhard Carl, Saeed, Hayder

“…Introduction: Low socioeconomic status (SES) has been shown to shorten survival in classical Hodgkin lymphoma (cHL). We sought to determine if differences in…”
Get full text

Weekly Dosing of Bortezomib in RVD Achieves Minimal Toxicity with No Reduction in Efficacy in a Diverse Cohort of Multiple Myeloma Patients by Hussaini, Syed, Gill, Amitoj, Gosain, Rahul, Rai, Shesh, Wu, Xiaoyong, Rhodes, Jill, Basu, Soumit K., Chao, Ju-Hsien, Tse, William, Herzig, Geoffrey P., Herzig, Roger H., Krem, Maxwell M.

“…Introduction: Lenalidomide, bortezomib, and dexamethasone is a standard of care in the treatment of fit multiple myeloma patients due to high efficacy, with…”
Get full text

Consolidative Radiation with Chemotherapy in Early Stage Classical Hodgkin Lymphoma with Unfavorable Risk: The Kentucky Experience by Myint, Zin W, Shrestha, Runa, Nee, Jaclyn, Huang, Bin, Durbin, Eric, Slone, Stacey, Goldberg, Amit, Zia, Maryam, Ramlal, Reshma, Monohan, Gregory, Herzig, Roger H., Fleischman, Roger A., Hildebrandt, Gerhard Carl, Saeed, Hayder

“…Introduction: Early stage classical Hodgkin lymphoma (cHL) carries good prognosis. Patients with B symptoms have been found to have unfavorable risk. Due to…”
Get full text

Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow by Phillips, G L, Herzig, R H, Lazarus, H M, Fay, J W, Wolff, S N, Mill, W B, Lin, H, Thomas, P R, Glasgow, G P, Shina, D C

“…Twenty-seven patients with malignant lymphoma in whom primary chemotherapy had failed and the prognosis was poor were treated with cyclophosphamide, total body…”
Get more information

Autologous transplantation for diffuse aggressive Non-Hodgkin lymphoma in first relapse or second remission by Vose, Julie M, Rizzo, Douglas J, Tao-Wu, Jing, Armitage, James O, Bashey, Asad, Burns, Linda J, Christiansen, Neal Paul, Freytes, Cesar O, Gale, Robert Peter, Gibson, John, Giralt, Sergio A, Herzig, Roger H, Lemaistre, Charles F, McCarthy, Philip L, Nimer, Stephen D, Petersen, Finn B, Schenkein, David P, Wiernik, Peter H, Wiley, Joseph M, Loberiza, Fausto R, Lazarus, Hillard M, van Biesen, Koen, Horowitz, Mary M

“…We evaluated the results of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with diffuse aggressive non-Hodgkin…”
Get full text

Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation by RATANATHARATHORN, V, NASH, R. A, VAN DER JAGT, R, HERZIG, R. H, LITZOW, M. R, WOLFF, S. N, LONGO, W. L, PETERSEN, F. B, KARANES, C, AVALOS, B, STORB, R, BUELL, D. N, PRZEPIORKA, D, MAHER, R. M, FITZSIMMONS, W. E, WINGARD, J. R, DEVINE, S. M, KLEIN, J. L, WEISDORF, D, FAY, J. W, NADEMANEE, A, ANTIN, J. H, CHRISTIANSEN, N. P

“…We report the results of a phase III open-label, randomized, multicenter trial comparing tacrolimus/methotrexate to cyclosporine/methotrexate for…”
Get full text

T-Cell Large Granular Lymphocyte Leukemia of Donor Origin Following Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia by Rabinowits, Guilherme, Herzig, Roger H., Herzig, Geoffrey P.

“…Lymphoproliferative disorders are a recognized complication of allogeneic hematopoietic cell transplantation (HCT). Most are B-cell disorders, often associated…”
Get full text

Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study by Herzig, R H, Herzig, G P, Graw, Jr, R G, Bull, M I, Ray, K K

“…We prospectively randomized 27 granulocytopenic patients who experienced a total of 30 episodes of gram-negative septicemia. The control group received an…”
Get more information

Comparison of Preparative Regimens in Transplants for Children With Acute Lymphoblastic Leukemia by DAVIES, S. M, RAMSAY, N. K. C, HENSLEE-DOWNEY, P. J, HERZIG, R. H, HUTCHINSON, R, KEATING, A, LAZARUS, H. M, MILONE, G. A, NEUDORF, S, PEREZ, W. S, POWLES, R. L, PRENTICE, H. G, KLEIN, J. P, SCHILLER, G, SOCIE, G, VOWELS, M, WILEY, J, YEAGER, A, HOROWITZ, M. M, WEISDORF, D. J, BOLWELL, B, CAHN, J.-Y, CAMITTA, B. M, GALE, R. P, GIRALT, S, HEILMANN, C

“…Preparative regimens involving total-body irradiation (TBI) produce significant late toxicities in some children who receive bone marrow transplants, including…”
Get full text

Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: Predictors and clinical relevance by Pecora, Andrew L, Lazarus, Hillard M, Jennis, Andrew A, Preti, Robert A, Goldberg, Stuart L, Rowley, Scott D, Cantwell, Susan, Cooper, Brenda W, Copelan, Edward A, Herzig, Roger H, Meagher, Richard, Kennedy, M.John, Akard, Luke P, Jansen, Jan, Ross, Amy, Prilutskaya, Marina, Glassco, John, Kahn, Douglas, Moss, Thomas J

“…The incidence and clinical relevance of tumor cells contaminating the stem cell products of patients with advanced breast cancer treated with high-dose…”
Get full text

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities by CHAMPLIN, R. E, PASSWEG, J. R, GOLDMAN, J. M, GRATWOHL, A, GORDON-SMITH, E. C, HENSLEE-DOWNEY, P. J, HERZIG, R. H, KLEIN, J. P, MARMONT, A. M, O'REILLY, R. J, RINGDEN, O, SLAVIN, S, ZHANG, M.-J, SOBOCINSKI, K. A, SPECK, B, WEINER, R. S, HOROWITZ, M. M, ROWLINGS, P. A, PELZ, C. J, ATKINSON, K. A, BARRETT, A. J, CAHN, J.-Y, DROBYSKI, W. R, GALE, R. P

“…T-cell depletion of donor marrow decreases graft-versus-host disease resulting from transplants from unrelated and human leukocyte antigen (HLA)-mismatched…”
Get full text

Risk Factors for Major Transplant Related Outcomes In Pediatric Patients with Chronic Graft-Versus-Host Disease by Jacobsohn, David A., Arora, Mukta, Klein, John P., Antin, Joseph H., Bolwell, Brian J., Boyiadzis, Michael, Cahn, Jean-Yves, Cairo, Mitchell S., Cutler, Corey S., Flowers, Mary E.D., Gale, Robert P., Hassebroek, Anna, Herzig, Roger H., Horowitz, Mary M., Isola, Luis, Klumpp, Thomas R., Lee, Stephanie J., Petersdorf, Effie W., Santarone, Stella, Schouten, Harry C., Spellman, Stephen, Urbano, Alvaro, Weisdorf, Daniel J., Wingard, John R., Pavletic, Steven Z.

“…Abstract 211 The adverse impact of chronic GVHD (cGvHD) on health and quality of life is especially critical in children because of their longer life…”
Get full text

Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis by Arora, Mukta, Klein, John P., Antin, Joseph H., Bolwell, Brian J., Boyiadzis, Michael, Cahn, Jean-Yves, Cairo, Mitchell S., Cutler, Corey S., Flowers, Mary E.D., Gale, Robert P., Hassebroek, Anna, Herzig, Roger H., Horowitz, Mary M., Isola, Luis, Jacobsohn, David A., Klumpp, Thomas R., Lee, Stephanie J., Petersdorf, Effie W., Santarone, Stella, Schouten, Harry C., Spellman, Stephen, Urbano, Alvaro, Weisdorf, Daniel J., Wingard, John R., Pavletic, Steven Z.

“…Abstract 898 Chronic graft-versus-host disease (cGvHD) remains a major barrier to allogeneic (allo) hematopoietic cell transplant (HCT). Previous studies have…”
Get full text